Startups
Atalanta is a mission-driven firm with extensive advocacy, campaigning and strategic communications expertise.
We work with inspirational leaders and global organisations - whether in the philanthropic, corporate or political fields - to amplify the impact of their work. We help them shape public opinion, run for political office, raise awareness of global issues, and mobilise communities and funding for their initiatives. Using traditional and digital communications skills, we give our partners and clients a platform to change the world.
We have a particular focus on advancing women's leadership worldwide and accelerating programmes that tackle the root causes of gender inequality. We only work with clients who are committed to gender equality, and we dedicate a portion of our time to providing pro-bono or low-bono support to clients aligned with our mission who have limited resources.
We work with inspirational leaders and global organisations - whether in the philanthropic, corporate or political fields - to amplify the impact of their work. We help them shape public opinion, run for political office, raise awareness of global issues, and mobilise communities and funding for their initiatives. Using traditional and digital communications skills, we give our partners and clients a platform to change the world.
We have a particular focus on advancing women's leadership worldwide and accelerating programmes that tackle the root causes of gender inequality. We only work with clients who are committed to gender equality, and we dedicate a portion of our time to providing pro-bono or low-bono support to clients aligned with our mission who have limited resources.
Overview
Location
United Kingdom, England, London
Employees
11-50
Founded date
2017
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 11, 2021 | Atalanta Therapeutics Raises $110M in Series A Funding | Atalanta Therapeutics, a Boston, MA-based biotechnology company pioneering new treatment options for neurodegenerative diseases, raised $110m in Series A funding. The financing was provided exclusively by F-Prime Capital. Additionally, Atal... |
| Jan 11, 2021 | Atalanta Therapeutics Raises $110M in Series A Funding | Atalanta Therapeutics, a Boston, MA-based biotechnology company pioneering new treatment options for neurodegenerative diseases, raised $110m in Series A funding. The financing was provided exclusively by F-Prime Capital. Additionally, Atal... |
Reviews 0
FAQ about Atalanta
When was Atalanta founded?
Atalanta was founded in 2017.
What has the press written about Atalanta?
Parsers VC has collected 3 articles mentioning Atalanta, among them “Atalanta Therapeutics Raises $110M in Series A Funding” (Jan 11, 2021) and “Atalanta Therapeutics Raises $110M in Series A Funding” (Jan 11, 2021).
Is Atalanta still active?
Yes, Atalanta is active; its latest activity on Parsers VC dates from Oct 6, 2022.